pyrimidine has been researched along with Angiogenesis, Pathologic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhandari, S; Bhargava, SK; Reddy, TS; Reddy, VG; Sakla, AP; Sana, S; Shankaraiah, N; Tokala, R | 1 |
| Cui, DB; Guan, HY; Li, YJ; Liao, SG; Liu, T; Wang, S; Wang, YC; Xu, GB; Yan, GY; Yang, D; Zhang, H; Zhang, RH; Zhao, YL; Zhou, M; Zhou, YH | 1 |
| Kim, D; Kwon, A; Lee, BY; Min, KH; Nguyen, HK; Song, J; Suh, W; Yoo, J | 1 |
| Buttar, D; Edge, M; Emery, SC; Fitzek, M; Forder, C; Griffen, A; Hayter, B; Hayward, CF; Hopcroft, PJ; Luke, RW; Page, K; Stawpert, J; Wright, A | 1 |
4 other study(ies) available for pyrimidine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indoles; Molecular Structure; Neovascularization, Pathologic; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship; Tumor Cells, Cultured; Urea; Vascular Endothelial Growth Factor Receptor-2 | 2020 |
Design, synthesis, and biological evaluation of 2,4-diamino pyrimidine derivatives as potent FAK inhibitors with anti-cancer and anti-angiogenesis activities.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Focal Adhesion Kinase 1; Humans; Molecular Structure; Neovascularization, Pathologic; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship | 2021 |
Structure-Activity Relationship of Indole-Tethered Pyrimidine Derivatives that Concurrently Inhibit Epidermal Growth Factor Receptor and Other Angiokinases.
Topics: Angiogenesis Inhibitors; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; ErbB Receptors; Human Umbilical Vein Endothelial Cells; Humans; Indazoles; Indoles; Inhibitory Concentration 50; Lung Neoplasms; Molecular Docking Simulation; Neovascularization, Pathologic; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Structure-Activity Relationship; Sulfonamides; Vascular Endothelial Growth Factor A | 2015 |
Discovery of imidazole vinyl pyrimidines as a novel class of kinase inhibitors which inhibit Tie-2 and are orally bioavailable.
Topics: Administration, Oral; Biological Availability; Chemistry, Pharmaceutical; Drug Design; Humans; Imidazoles; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Neovascularization, Pathologic; Protein Kinase Inhibitors; Pyrimidines; Receptor, TIE-2; Structure-Activity Relationship | 2008 |